Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Another Set Of Eyes: US FDA Authorizes AI Software To Spot Prostate Cancer

Executive Summary

The Paige Prostate is a first-of-its-kind digital prostate imaging analysis software that can act as an extra pair of eyes to help pathologists spot cancer cells.

You may also be interested in...



Digital Health Roundup, August/September 2021: Record Digital Health Funding Q1-3 Of $21.3Bn, AAOS Highlights, Regulatory Updates

In this roundup of developments in digital health, we highlight the key news and announcements from August and September.

New FDA Web Page Spotlights AI/ML Progress

The US agency has published a list of more than 300 artificial intelligence/machine learning devices it has allowed on the market, highlighting the work it has done to review these new and complicated products.

Paige Obtains NHSx Award Allowing It To Launch AI Prostate Test

NHSx has awarded Paige an undisclosed sum of money to support development of its AI-powered prostate cancer detection tool in clinical settings in the UK.

Related Content

Topics

UsernamePublicRestriction

Register

MT144487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel